跳至主要内容
临床试验/NL-OMON23633
NL-OMON23633已完成不适用

The effect of dietary lactose in lactase non-persistent individuals on gut microbiota

Wageningen Food & Biobased Research0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Apparently healthy men and women (based on questionnaire)
  • Asian ethnicity
  • Age between 18 and 50 years
  • Body mass index (BMI) between 18.5 and 30 kg/m2
  • LNP genotype (based on buccal swab testing)
  • Avoiding dietary lactose in habitual diet (self-reported via questionnaire)
  • Regular stool frequency (on average at least once every two days)

排除标准

  • Any metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes, anaemia, hepatitis, cardiovascular disease), judged by the medical doctor
  • History of gastro-intestinal surgery or having (serious) gastrointestinal discomfort
  • Use of pre- and/or probiotics
  • Use of medication that may influence the study results, such as laxatives and lactase preparations (e.g. Kerutab). Use of medication will be judged by the medical supervisor.
  • Having used antibiotics in the 6 months prior to the start of the study
  • Reported slimming or medically prescribed diet
  • Current smokers
  • Alcohol intake =2 (women) or =4 (men) glasses of alcoholic beverages per day
  • Pregnant or lactating (or having the wish to become pregnant during the study period, self-reported)
  • Abuse of illicit drugs
  • Having food allergies (food intolerances are acceptable)
  • Insufficient proficiency in English to understand information brochure and questionnaires
  • Participation in another clinical trial at the same time
  • Being an employee of the department Consumer Science & Health group of Wageningen Food & Biobased Research, Human Nutrition Department of Wageningen University, or FrieslandCampina.

研究者

发起方
Wageningen Food & Biobased Research

相似试验

The effect of dietary lactose in lactase... | 临床试验